CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Increase in number of pipeline drugs
3.3.1.2.Upsurge in patient population
3.3.1.3.Surge in number of patient assistance programs (PAPs )

3.3.2.Restraint

3.3.2.1.Unspecified etiology of the disease

3.3.3.Opportunities

3.3.3.1.Introduction of disease-modifying drugs
3.3.3.2.Use of off-label drugs

CHAPTER 4:MS THERAPIES MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Immunosuppressants

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Immunomodulators

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

CHAPTER 5:MS THERAPIES MARKET, BY ROUTE OF ADMINISTRATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Oral

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Injectable

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Intravenous

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

CHAPTER 6:MS THERAPIES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends and opportunities
6.2.2.Market analysis by country

6.2.2.1.U.S.

6.2.2.1.1.U.S. market size and forecast, by type
6.2.2.1.2.U.S. market size and forecast, by route of administration

6.2.2.2.Canada

6.2.2.2.1.Canada market size and forecast, by type
6.2.2.2.2.Canada market size and forecast, by route of administration

6.2.2.3.Mexico

6.2.2.3.1.Mexico market size and forecast, by type
6.2.2.3.2.Mexico market size and forecast, by route of administration

6.3.Europe

6.3.1.Key market trends and opportunities
6.3.2.Market analysis by country

6.3.2.1.UK

6.3.2.1.1.UK market size and forecast, by type
6.3.2.1.2.UK market size and forecast, by route of administration

6.3.2.2.Germany

6.3.2.2.1.Germany market size and forecast, by type
6.3.2.2.2.Germany market size and forecast, by route of administration

6.3.2.3.France

6.3.2.3.1.France market size and forecast, by type
6.3.2.3.2.France market size and forecast, by route of administration

6.3.2.5.Italy


6.3.2.5.1.Italy market size and forecast, by type
6.3.2.5.2.Italy market size and forecast, by route of administration

6.3.2.6.Spain

6.3.2.6.1.Spain market size and forecast, by type
6.3.2.6.2.Spain market size and forecast, by route of administration

6.3.2.7.Rest of Europe

6.3.2.7.1.Rest of Europe market size and forecast, by type
6.3.2.7.2.Rest of Europe market size and forecast, by route of administration

6.4.Asia-Pacific

6.4.1.Key market trends and opportunities
6.4.2.Market analysis by country

6.4.2.1.Japan

6.4.2.1.1.Japan market size and forecast, by type
6.4.2.1.2.Japan market size and forecast, by route of administration

6.4.2.2.China

6.4.2.2.1.China market size and forecast, by type
6.4.2.2.2.China market size and forecast, by route of administration

6.4.2.3.Australia

6.4.2.3.1.Australia market size and forecast, by type
6.4.2.3.2.Australia market size and forecast, by route of administration

6.4.2.4.India

6.4.2.4.1.India market size and forecast, by type
6.4.2.4.2.India market size and forecast, by route of administration

6.4.2.5.Rest of Asia-Pacific

6.4.2.5.1.Rest of Asia-Pacific market size and forecast, by type
6.4.2.5.2.Rest of Asia-Pacific market size and forecast, by route of administration

6.5.LAMEA

6.5.1.Key market trends and opportunities
6.5.2.Market analysis by country

6.5.2.1.Brazil

6.5.2.1.1.Brazil market size and forecast, by type
6.5.2.1.2.Brazil market size and forecast, by route of administration

6.5.2.2.South Africa6.5.2.2.1.South Africa market size and forecast, by type


6.5.2.2.2.South Africa market size and forecast, by route of administration

6.5.2.3.Saudi Arabia

6.5.2.3.1.Saudi Arabia market size and forecast, by type
6.5.2.3.2.Saudi Arabia market size and forecast, by route of administration

6.5.2.4.Rest of LAMEA

6.5.2.4.1.Rest of LAMEA market size and forecast, by type
6.5.2.4.2.Rest of LAMEA market size and forecast, by route of administration

CHAPTER 7:COMPANY PROFILES

7.1.ABBVIE INC.

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance

7.2.BAYER AG.

7.2.1.Company overview
7.2.2.Operating business segments
7.2.3.Product portfolio
7.2.4.Business performance

7.3.BIOGEN

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments

7.4.BRISTOL-MYERS SQUIBB COMPANY

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance

7.5.F. HOFFMANN-LA ROCHE LTD.

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Business performance
7.5.5.Key strategic moves and developments

7.6.MERCK KGAA

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance

7.7.NOVARTIS AG.

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments

7.8.PFIZER INC.

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance

7.9.SANOFI

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance

7.10.TEVA PHARMACEUTICAL INDUSTRIES LTD.

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments